ASLAN Pharmaceuticals to Present Additional Data From ASLAN004 Proof-of-Concept Study at Two Upcoming Winter Dermatology Conferences ASLAN Pharmaceuticals , a. | January 11, 2022
11.01.2022 - - Data from Phase 1b dose escalation cohorts to be presented during the 2022 Winter Clinical Dermatology Conference, held in-person from 14-19 January, 2022, in Koloa, Hawaii - Data will also be presented as an encore presentation at the .